The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Functional genomics of PCOS: from GWAS to molecular mechanisms
Open accessAbstract
Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by increased ovarian androgen biosynthesis, anovulation, and infertility. PCOS has a strong heritable component based on familial clustering and twin studies. Genome-wide association studies (GWAS) identified several PCOS candidate loci including, DENND1A, LHCGR, FSHR, ZNF217, YAP1, INSR, RAB5B, and C9orf3. Here, we review the functional roles of strong PCOS candidate loci focusing on FSHR, LHCGR, INSR and DENND1A. We propose that these candidates comprise a hierarchical signaling network by which DENND1A, LHCGR, INSR, RAB5B, adapter proteins, and associated downstream signaling cascades converge to regulate theca cell androgen biosynthesis. Future elucidation of the functional gene networks predicted by the PCOS GWAS will result in new diagnostic and therapeutic approaches for women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Rab GTPases as coordinators of vesicle traffic
Stenmark, H. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2728 · Cited by 3,413
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Self-citationLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationBasu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678
Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8088 · Cited by 405
Self-citationEvidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
Gilling‐Smith, C., Story, H., Rogers, V., & Franks, S. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2321049.x · Cited by 301
Research works printed but not linked: 75
- De Leo, 2010, Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome, Contraception, 82, 276, 10.1016/j.contraception.2010.04.002 · DOI
- Azziz, 2003, Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome, Fertil. Steril., 79, 932, 10.1016/S0015-0282(02)04914-2 · DOI
- Azziz, 2001, Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial, J. Clin. Endocrinol. Metab., 86, 1626
- Gilling-Smith, 1994, Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries, J. Clin. Endocrinol. Metab., 79, 1158
- Nelson, 1999, Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries, Mol. Endocrinol., 13, 946, 10.1210/mend.13.6.0311 · DOI · Paper page
- Wickenheisser, 2000, Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells, J. Clin. Endocrinol. Metab., 85, 2304
- Magoffin, 2006, Ovarian enzyme activities in women with polycystic ovary syndrome, Fertil. Steril., 86, S9, 10.1016/j.fertnstert.2006.03.015 · DOI
- Jakimiuk, 2001, Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries, J. Clin. Endocrinol. Metab., 86, 1318
- Wickenheisser, 2005, Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 90, 1720, 10.1210/jc.2004-1860 · DOI
- Wickenheisser, 2004, Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1, Mol. Endocrinol., 18, 588, 10.1210/me.2003-0090 · DOI
- Wood, 2004, The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling, J. Reprod. Immunol., 63, 51, 10.1016/j.jri.2004.01.010 · DOI
- Wood, 2003, The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis, J. Biol. Chem., 278, 26380, 10.1074/jbc.M300688200 · DOI · Paper page
- Ho, 2005, Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells, J. Clin. Endocrinol. Metab., 90, 6596, 10.1210/jc.2005-0890 · DOI
- Legro, 1998, Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome, Proc. Natl. Acad. Sci. U.S.A., 95, 14956, 10.1073/pnas.95.25.14956 · DOI · Paper page
- Strauss, 2012, Persistence pays off for PCOS gene prospectors, J. Clin. Endocrinol. Metab., 97, 2286, 10.1210/jc.2012-2109 · DOI
- Goodarzi, 2012, Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts, J. Med. Genet., 49, 90, 10.1136/jmedgenet-2011-100427 · DOI · Paper page
- Welt, 2012, Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry, J. Clin. Endocrinol. Metab., 97, E1342, 10.1210/jc.2011-3478 · DOI · Paper page
- Eriksen, 2013, Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS), PLoS ONE, 8, e77186, 10.1371/journal.pone.0077186 · DOI
- Louwers, 2013, Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 98, E2006, 10.1210/jc.2013-2495 · DOI
- Franks, 1999, Insulin action in the normal and polycystic ovary, Endocrinol. Metab. Clin. North Am., 28, 361, 10.1016/S0889-8529(05)70074-8 · DOI · Paper page
- Unsal, 2009, Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome, J. Assist. Reprod. Genet., 26, 205, 10.1007/s10815-009-9308-8 · DOI
- Dolfin, 2011, FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women, J. Assist. Reprod. Genet., 28, 925, 10.1007/s10815-011-9619-4 · DOI
- Fu, 2013, Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women, J. Assist. Reprod. Genet., 30, 717, 10.1007/s10815-013-9979-z · DOI
- Ioannidis, 2010, Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis, Mol. Genet. Metab., 99, 174, 10.1016/j.ymgme.2009.10.013 · DOI
- Talbot, 1996, Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome, J. Clin. Endocrinol. Metab., 81, 1979
- Mutharasan, 2013, Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry, J. Clin. Endocrinol. Metab., 98, E185, 10.1210/jc.2012-2471 · DOI
- Gu, 2010, Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome, Int. J. Mol. Med., 26, 107
- Wu, 2014, Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China, J. Assist. Reprod. Genet., 31, 371, 10.1007/s10815-013-0166-z · DOI
- Aittomaki, 1995, Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure, Cell, 82, 959, 10.1016/0092-8674(95)90275-9 · DOI · Paper page
- Huhtaniemi, 2000, The Parkes lecture. Mutations of gonadotrophin and gonadotrophin receptor genes: what do they teach us about reproductive physiology?, J. Reprod. Fertil., 119, 173, 10.1530/reprod/119.2.173 · doi:10.1530/reprod/119.2.173
- Du, 2010, Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome, Mol. Genet. Metab., 100, 292, 10.1016/j.ymgme.2010.03.018 · DOI
- Conway, 1999, Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome, Clin. Endocrinol., 51, 97, 10.1046/j.1365-2265.1999.00745.x · DOI
- Overbeek, 2009, Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome, Hum. Reprod., 24, 2007, 10.1093/humrep/dep114 · DOI
- Sudo, 2002, Genetic and functional analyses of polymorphisms in the human FSH receptor gene, Mol. Hum. Reprod., 8, 893, 10.1093/molehr/8.10.893 · DOI · Paper page
- Simoni, 2002, Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction, Hum. Reprod. Update, 8, 413, 10.1093/humupd/8.5.413 · DOI · Paper page
- Toledo, 1996, An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female, J. Clin. Endocrinol. Metab., 81, 3850
- Liu, 2012, Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome, Reprod. Biol. Endocrinol., 10, 36, 10.1186/1477-7827-10-36 · DOI
- Latronico, 2000, The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary–gonadal axis in both sexes, Clin. Endocrinol., 53, 609, 10.1046/j.1365-2265.2000.01135.x · DOI
- Piersma, 2007, LH receptor gene mutations and polymorphisms: an overview, Mol. Cell. Endocrinol., 260–262, 282, 10.1016/j.mce.2005.11.048 · DOI
- Capalbo, 2012, The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2.7-fold increased risk of polycystic ovary syndrome in a Sardinian population, Clin. Endocrinol., 77, 113, 10.1111/j.1365-2265.2012.04372.x · DOI
- Rager, 2006, Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN, Sci. World J., 6, 116, 10.1100/tsw.2006.23 · DOI
- Globerman, 1998, Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance), Int. J. Obes. Relat. Metab. Disord., 22, 349, 10.1038/sj.ijo.0800593 · DOI
- Urbanek, 1999, Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin, Proc. Natl. Acad. Sci. U.S.A., 96, 8573, 10.1073/pnas.96.15.8573 · DOI · Paper page
- Villuendas, 2003, Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome, Fertil. Steril., 79, 219, 10.1016/S0015-0282(02)04570-3 · DOI
- Tucci, 2001, Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus, J. Clin. Endocrinol. Metab., 86, 446, 10.1210/jcem.86.1.7274 · DOI
- Stewart, 2006, Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity, J. Clin. Endocrinol. Metab., 91, 4112, 10.1210/jc.2006-0951 · DOI
- Ewens, 2010, Family-based analysis of candidate genes for polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 95, 2306, 10.1210/jc.2009-2703 · DOI
- Xie, 2013, Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case–control study and meta-analysis, Reprod. Biomed. Online, 26, 168, 10.1016/j.rbmo.2012.10.014 · DOI
- Lee, 2006, Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population, Fertil. Steril., 86, 380, 10.1016/j.fertnstert.2005.12.073 · DOI
- Chen, 2004, Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome, Chin. J. Obstet. Gynecol., 39, 582
- Jin, 2006, A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS, Mol. Hum. Reprod., 12, 151, 10.1093/molehr/gal022 · DOI
- Mukherjee, 2009, Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome, Eur. J. Endocrinol., 160, 855, 10.1530/EJE-08-0932 · DOI
- Ramezani Tehrani, 2013, Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS, Iran. J. Reprod. Med., 11, 185
- Lee, 2008, A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome, Fertil. Steril., 89, 1213, 10.1016/j.fertnstert.2007.05.026 · DOI
- Xu, 2011, Family association study between INSR gene polymorphisms and PCOS in Han Chinese, Reprod. Biol. Endocrinol., 9, 76, 10.1186/1477-7827-9-76 · DOI
- Goodarzi, 2011, Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome, Fertil. Steril., 95, 1736, 10.1016/j.fertnstert.2011.01.015 · DOI
- Hanzu, 2010, Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe, Fertil. Steril., 94, 2389, 10.1016/j.fertnstert.2010.04.029 · doi:10.1016/j.fertnstert.2010.04.029
- Marat, 2011, DENN domain proteins: regulators of Rab GTPases, J. Biol. Chem., 286, 13791, 10.1074/jbc.R110.217067 · DOI · Paper page
- Legro, 2002, Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 2134, 10.1210/jcem.87.5.8387 · doi:10.1210/jcem.87.5.8387 · Paper page
- Ehrmann, 1995, Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion, Endocr. Rev., 16, 322, 10.1210/er.16.3.322 · DOI · Paper page
- Yildiz, 2007, The adrenal and polycystic ovary syndrome, Rev. Endocr. Metab. Disord., 8, 331, 10.1007/s11154-007-9054-0 · DOI
- Cui, 2013, Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women, Hum. Reprod., 28, 538, 10.1093/humrep/des424 · DOI
- Wang, 2012, Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma, Gynecol. Oncol., 2, 403, 10.1016/j.ygyno.2012.08.007 · DOI
- Allaire, 2010, The Connecdenn DENN domain: a GEF for Rab35 mediating cargo-specific exit from early endosomes, Mol. Cell, 37, 370, 10.1016/j.molcel.2009.12.037 · DOI · Paper page
- Cowger, 2007, Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence, Oncogene, 26, 3378, 10.1038/sj.onc.1210126 · DOI
- Yuan, 2009, TOX3 regulates calcium-dependent transcription in neurons, Proc. Natl. Acad. Sci. U.S.A., 106, 2909, 10.1073/pnas.0805555106 · DOI
- Munir, 2004, Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells, Endocrinology, 145, 175, 10.1210/en.2003-0329 · DOI · Paper page
- Zhang, 2012, Activation and significance of the PI3K/Akt pathway in endometrium with polycystic ovary syndrome patients, Zhonghua fu chan ke za zhi, 47, 19
- Ciaraldi, 2000, Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity, J. Pediatr. Endocrinol. Metab., 13, 1291
- Hojlund, 2008, Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment, Diabetes, 57, 357, 10.2337/db07-0706 · DOI
- Dunaif, 2013, Renaming PCOS – a two-state solution, J. Clin. Endocrinol. Metab., 98, 4325, 10.1210/jc.2013-2040 · DOI
- National Institutes of Health (2012) Evidence-Based Methodology Workshop for Polycystic Ovarian Syndrome December 3–5, 2012, https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf
- Marat, 2012, Connecdenn 3/DENND1C binds actin linking Rab35 activation to the actin cytoskeleton, Mol. Biol. Cell, 23, 163, 10.1091/mbc.E11-05-0474 · DOI
- Stenmark, 2001, The Rab GTPase family, Genome Biol., 2, 10.1186/gb-2001-2-5-reviews3007 · DOI
- Noro, 2003, Molecular dissection of the architectural transcription factor HMGA2, Biochemistry, 42, 4569, 10.1021/bi026605k · DOI
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationRosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationDay, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
Self-citationTata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434
Metadata
- Authors
- McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 26
- Issue
- 3
- Pages
- 118-124
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W1984125311
- Cited by
- 219
- References
- 13
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional genomics of PCOS: from GWAS to molecular mechanisms. https://app.cochat.ai/papers/10.1016/j.tem.2014.12.004
- The paper
- McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F. (2015). Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2014.12.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.